Insider Moves Spotlight Biotech, Food and Mining-Linked Stocks Amid Mixed Valuation Signals
A review of Tuesday’s insider filings shows significant purchases by company directors and executives at several U.S.-listed firms, including biotech and food companies, alongside large sales by senior executives at technology and biopharma firms. Transactions include buy orders from Lipocine, Contango Silver & Gold, Lamb Weston, Fuller H B Co and …